サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：優しい細胞解離試薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略と予測、2023年から2031年
市場調査レポート
商品コード
1280665

優しい細胞解離試薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略と予測、2023年から2031年

Gentle Cell Dissociation Reagent Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
優しい細胞解離試薬の市場規模、市場シェア、アプリケーション分析、地域展望、成長動向、主要企業、競争戦略と予測、2023年から2031年
出版日: 2023年05月19日
発行: Acute Market Reports
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

やさしい細胞解離試薬市場は、ライフサイエンス業界の成長市場です。やさしい細胞解離試薬は、酵素を使わない解離試薬の一種で、初代細胞、幹細胞、腫瘍細胞など様々な種類の細胞の解離に使用することができます。やさしい細胞解離試薬市場は、細胞ベースの研究および細胞治療の需要の増加により、今後数年間で成長すると予想されます。同市場は、2023年から2031年の予測期間中にCAGR 6.5%で成長すると予想されます。創薬に向けたセルベースアッセイの採用の増加や慢性疾患の有病率の上昇が、市場の成長を促進する主な要因のひとつです。

セルベース研究の需要拡大

細胞ベースの研究は、創薬開発に不可欠な要素となっています。医薬品候補をより正確かつ効率的に検査する必要があるため、セルベースアッセイの需要が増加しています。 その結果、やさしい細胞解離試薬の需要はますます高まっています。セルベースアッセイの需要の増加は、やさしい細胞解離試薬市場の成長を促進すると予想されます。

慢性疾患の有病率の上昇

がん、神経疾患、心血管疾患などの慢性疾患の有病率の上昇が、細胞ベースの治療法に対する需要を促進しています。やさしい細胞解離試薬は、細胞ベース療法に使用される幹細胞の分離と拡張に使用されます。Grand View Research社のレポートによると、慢性疾患の有病率の増加が世界の幹細胞治療市場の成長を促進し、それがやさしい細胞解離試薬市場の成長を促進すると予想されています。

バイオテクノロジーと製薬業界の進歩

バイオテクノロジーと製薬業界は、近年、著しい進歩を遂げています。研究開発活動への投資の増加により、革新的な医薬品や治療法が開発されています。やさしい細胞解離試薬は、創薬と開発のプロセスにおいて極めて重要であり、革新的な医薬品に対する需要の高まりが、やさしい細胞解離試薬市場の成長を促進すると期待されています。Zion Market Researchのレポートによると、バイオテクノロジーと製薬産業への投資の増加が、世界のやさしい細胞解離試薬市場の成長を促進すると予想されています。

やさしい細胞解離試薬の認知度の低さとコストの高さ

やさしい細胞解離試薬の需要が増加しているにもかかわらず、これらの試薬の認知度が低く、コストが高いことが、市場の抑制要因となっています。多くの研究者はやさしい細胞解離試薬の利点を知らないため、過酷な細胞解離の方法を使い続けています。さらに、やさしい細胞解離試薬のコストは従来の方法と比較して高いため、その採用は制限されています。コストが高いのは、高品質の酵素やその他の試薬を使用しているためと考えられます。さらに、やさしい細胞解離試薬の使用には、特定のプロトコルや機器が必要であり、追加投資が必要となる場合があります。やさしい細胞解離試薬の認知度の低さとコストの高さは、市場の成長を妨げると予想されます。また、この阻害要因に対処するために、メーカーはやさしい細胞解離試薬の利点について研究者や研究開発者の認識を高め、費用対効果の高い試薬を開発する必要があると指摘しています。

収益シェアを独占する結合組織セグメント

様々な結合組織からの細胞の分離と培養におけるやさしい細胞解離試薬の使用の増加により、2022年には結合組織が最大の収益シェアを占めています。結合組織細胞は、様々な臓器や組織の研究開発において重要な役割を担っており、その単離や培養は、いくつかの生物医学研究において不可欠となっています。一方、上皮組織セグメントは、2023年から2031年の予測期間中、最も高いCAGRで成長すると予想されています。上皮細胞は、さまざまな臓器や組織を覆う1次細胞であり、その分離と培養は、いくつかの生物医学的な調査において極めて重要です。研究目的での上皮細胞の需要の増加は、やさしい細胞解離試薬市場の成長を促進すると予想されます。

収益シェアを独占するラボラトリーセグメント

細胞の単離や培養のためのさまざまな実験手順でやさしい細胞解離試薬の使用が増加していることから、2022年にはラボラトリーセグメントが市場の最大の収益シェアを占めています。創薬・研究開発、がん研究、その他の生物医学研究におけるセルベースアッセイの需要の高まりは、このセグメントの市場成長を促進すると期待されています。病院分野は、予測期間中に最も高いCAGRで成長すると予想されます。がんなどの慢性疾患の有病率の増加や個別化医療に対する需要の高まりが、このセグメントにおけるやさしい細胞解離試薬市場の成長を促進すると予想されます。病院やクリニックでは、診断や治療を目的とした細胞の分離・培養のためにやさしい細胞解離試薬のを採用するケースが増えています。

北米が収益をリードし、APACが市場成長をリードする

北米は、この地域に多数のバイオテクノロジーおよび製薬会社、学術・研究機関、病院が存在することから、2022年の市場において最大のシェアを占めています。創薬開発、がん研究、その他の生物医学研究においてセルベースアッセイの採用が増加していることが、同地域の市場成長を促進すると予想されます。さらに、がんや自己免疫疾患などの慢性疾患の有病率の増加も、この地域の市場成長を促進すると予想されます。アジア太平洋は、2023年から2031年の予測期間中、最も高いCAGRで成長すると予想されています。バイオメディカル研究開発への注力、ヘルスケアインフラへの投資の拡大、同地域における慢性疾患の有病率の上昇が、同地域の市場成長の原動力となると予想されます。また、個別化医療の導入が進み、創薬や薬剤開発のためのセルベースアッセイの需要が高まっていることも、この地域の市場の成長を促進すると予想されます。

予測期間中に競合が激化する見込み

世界のやさしい細胞解離試薬市場は競争が激しく、複数の大手企業が存在することが特徴です。市場で活動している主要なプレーヤーには、Thermo Fisher Scientific, Inc、Merck KGaA、STEMCELL Technologies、ATCC、MiltenyiBiotec GmbH、Biological Industries、PromoCell GmbH、Corning Incorporated、Lonza、HiMedia Laboratories、その他の注目すべきプレーヤーがあります。これらの企業は、市場での地位を強化するために、M&A、提携、パートナーシップ、製品発表などの戦略的イニシアティブに積極的に取り組んでいます。例えば、2021年5月、Thermo Fisher Scientific, Inc.は、次世代の細胞治療製造プラットフォームである新しいGibco CTS Rotea Counterflow Centrifugation Systemの発売を発表しました。このプラットフォームには、細胞療法や遺伝子療法の製造に最適化されたやさしい細胞解離試薬のが含まれています。個別化医療への注目の高まり、創薬・開発におけるセルベースアッセイの需要の高まり、慢性疾患の有病率の上昇が、予測期間中の市場成長を促進すると予想されます。

本レポートで回答した主な質問

やさしい細胞解離試薬市場の成長に影響を与える主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントと地域に関する主要な投資ポケットは何か？

2031年までの推定推計・市場予測

予測期間中に最も速いCAGRを占めるのはどのセグメントか？

より大きな市場シェアを持つ市場セグメントとその理由は？

低・中所得国はやさしい細胞解離試薬市場に投資しているか？

やさしい細胞解離試薬市場の地域別市場規模が最も大きいのはどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

やさしい細胞解離試薬市場の成長を促進する主要動向は何か？

世界のやさしい細胞解離試薬市場で存在感を高めるための主要な競合企業とその主要戦略は何か？

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界のやさしい細胞解離試薬市場
  • タイプ別の世界のやさしい細胞解離試薬市場 2022
  • 用途別の世界のやさしい細胞解離試薬市場 2022
  • 地域別の世界のやさしい細胞解離試薬市場 2022
  • 魅力的な投資提案：地域別 2022

第3章 やさしい細胞解離試薬市場：競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析：2022 vs 2031

第4章 やさしい細胞解離試薬市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のやさしい細胞解離試薬市場価値 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 やさしい細胞解離試薬市場、タイプ別： 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • 結合組織
    • 上皮組織
    • その他

第6章 やさしい細胞解離試薬市場、用途別： 2021-2031

  • 市場概要
  • 成長・収益分析：2022 vs 2031
  • 市場セグメンテーション
    • ラボ
    • 病院
    • その他

第7章 北米のやさしい細胞解離試薬市場： 2021-2031

  • 市場概要
  • やさしい細胞解離試薬市場、タイプ別： 2021-2031
  • やさしい細胞解離試薬市場、用途別： 2021-2031
  • やさしい細胞解離試薬市場、地域別： 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第8章 英国および欧州連合のやさしい細胞解離試薬市場： 2021-2031

  • 市場概要
  • やさしい細胞解離試薬市場、タイプ別： 2021-2031
  • やさしい細胞解離試薬市場、用途別： 2021-2031
  • やさしい細胞解離試薬市場、地域別： 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第9章 アジア太平洋のやさしい細胞解離試薬市場： 2021-2031

  • 市場概要
  • やさしい細胞解離試薬市場、タイプ別： 2021-2031
  • やさしい細胞解離試薬市場、用途別： 2021-2031
  • やさしい細胞解離試薬市場、地域別： 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第10章 ラテンアメリカのやさしい細胞解離試薬市場： 2021-2031

  • 市場概要
  • やさしい細胞解離試薬市場、タイプ別： 2021-2031
  • やさしい細胞解離試薬市場、用途別： 2021-2031
  • やさしい細胞解離試薬市場、地域別： 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第11章 中東およびアフリカのやさしい細胞解離試薬市場： 2021-2031

  • 市場概要
  • やさしい細胞解離試薬市場、タイプ別： 2021-2031
  • やさしい細胞解離試薬市場、用途別： 2021-2031
  • やさしい細胞解離試薬市場、地域別： 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • STEMCELL Technologies
  • ATCC
  • MiltenyiBiotec GmbH
  • Biological Industries
  • PromoCell GmbH
  • Corning Incorporated
  • Lonza
  • HiMedia Laboratories
  • その他の注目企業
図表

List of Tables

  • TABLE 1 Global Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 3 North America Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 4 North America Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 5 U.S. Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 6 U.S. Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 7 Canada Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 8 Canada Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 13 UK Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 14 UK Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Germany Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 16 Germany Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 17 Spain Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 18 Spain Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 19 Italy Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 20 Italy Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 21 France Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 22 France Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 25 Asia Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 26 Asia Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 27 China Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 28 China Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Japan Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 30 Japan Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 31 India Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 32 India Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 33 Australia Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 34 Australia Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 35 South Korea Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 36 South Korea Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 37 Latin America Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Latin America Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Brazil Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 40 Brazil Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 41 Mexico Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 42 Mexico Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 47 GCC Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 48 GCC Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 49 Africa Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Africa Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Gentle Cell Dissociation Reagent Market By Type, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Gentle Cell Dissociation Reagent Market By Application, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Gentle Cell Dissociation Reagent Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Gentle Cell Dissociation Reagent Market: Quality Assurance
  • FIG. 5 Global Gentle Cell Dissociation Reagent Market, By Type, 2022
  • FIG. 6 Global Gentle Cell Dissociation Reagent Market, By Application, 2022
  • FIG. 7 Global Gentle Cell Dissociation Reagent Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Gentle Cell Dissociation Reagent Market, 2022
  • FIG. 9 Market Positioning of Key Gentle Cell Dissociation Reagent Market Players, 2022
  • FIG. 10 Global Gentle Cell Dissociation Reagent Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Gentle Cell Dissociation Reagent Market, By Type, 2022 Vs 2031, %
  • FIG. 12 Global Gentle Cell Dissociation Reagent Market, By Application, 2022 Vs 2031, %
  • FIG. 13 U.S. Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 20 France Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 22 China Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 24 India Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Gentle Cell Dissociation Reagent Market (US$ Million), 2021 - 2031
目次
Product Code: 139584-05-23

The gentle cell dissociation reagent market is a growing market in the life sciences industry. The gentle cell dissociation reagent is a type of enzyme-free dissociation reagent that can be used to dissociate various cell types, including primary cells, stem cells, and tumor cells. The market for gentle cell dissociation reagents is expected to grow in the coming years due to the increasing demand for cell-based research and cell therapy. The market Is expected to grow at a CAGR of 6.5% during the forecast period of 2023 to 2031. The increasing adoption of cell-based assays for drug discovery and the rising prevalence of chronic diseases are some of the key factors driving the growth of the market.

Increasing Demand for Cell-Based Research

Cell-based research has become an essential part of drug discovery and development. The demand for cell-based assays has been increasing due to the need for a more accurate and efficient way of testing drug candidates. Gentle cell dissociation reagents are crucial in the process of isolating cells from tissues, enabling researchers to obtain a homogenous cell population for experiments. As a result, the demand for gentle cell dissociation reagents has been increasing. Increasing demand for cell-based assays is expected to drive the growth of the gentle cell dissociation reagent market.

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases, such as cancer, neurological disorders, and cardiovascular diseases, has been driving the demand for cell-based therapies. Gentle cell dissociation reagents are used in the isolation and expansion of stem cells, which are used in cell-based therapies. According to a report by Grand View Research, the increasing prevalence of chronic diseases is expected to drive the growth of the global stem cell therapy market, which in turn is expected to drive the growth of the gentle cell dissociation reagent market.

Advancements in Biotechnology and Pharmaceutical Industries

The biotechnology and pharmaceutical industries have been witnessing significant advancements in recent years. The increasing investment in research and development activities has resulted in the development of innovative drugs and therapies. Gentle cell dissociation reagents are crucial in the process of drug discovery and development, and the increasing demand for innovative drugs is expected to drive the growth of the gentle cell dissociation reagent market. According to a report by Zion Market Research, the increasing investment in the biotechnology and pharmaceutical industries is expected to drive the growth of the global gentle cell dissociation reagent market.

Limited Awareness and High Cost of Gentle Cell Dissociation Reagents

Despite the increasing demand for gentle cell dissociation reagents, the market is restrained by limited awareness and the high cost of these reagents. Many researchers and laboratories are not aware of the benefits of gentle cell dissociation reagents, and therefore, continue to use harsh methods of cell dissociation. Additionally, the cost of gentle cell dissociation reagents is higher compared to traditional methods, which limits their adoption. The high cost of these reagents can be attributed to the use of high-quality enzymes and other reagents in their formulation. Furthermore, the use of gentle cell dissociation reagents requires specific protocols and equipment, which may require additional investment. The limited awareness and high cost of gentle cell dissociation reagents are expected to hinder the growth of the market. The report also suggests that manufacturers need to increase awareness among researchers and laboratories about the benefits of gentle cell dissociation reagents and develop cost-effective reagents to address this restraint.

Connective Tissue Segment Dominating the Revenue Share

Connective tissue held the largest revenue share in 2022, owing to the increasing use of gentle cell dissociation reagents in the isolation and culture of cells from various connective tissues. Connective tissue cells play a vital role in the development of various organs and tissues, making their isolation and culture essential in several biomedical research studies. On the other hand, the epithelial tissue segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031. Epithelial cells are the primary cells that line various organs and tissues, and their isolation and culture are crucial in several biomedical research studies. The increasing demand for epithelial cells for research purposes is expected to drive the growth of the gentle cell dissociation reagent market.

The Laboratory Segment Dominating the Revenue Share

The laboratory segment held the largest revenue share of the market in 2022, owing to the increasing use of gentle cell dissociation reagents in various laboratory procedures for the isolation and culture of cells. The rising demand for cell-based assays in drug discovery and development, cancer research, and other biomedical studies is expected to drive the growth of the market in this segment. The hospital segment is expected to grow at the highest CAGR during the forecast period. The increasing prevalence of chronic diseases such as cancer and the rising demand for personalized medicine is expected to drive the growth of the gentle cell dissociation reagent market in this segment. Hospitals and clinics are increasingly adopting gentle cell dissociation reagents for the isolation and culture of cells for diagnosis and treatment purposes.

North America Leads the Revenue, while APAC to Lead the Market Growth

North America held the largest share of the market in 2022, owing to the presence of a large number of biotechnology and pharmaceutical companies, academic and research institutes, and hospitals in the region. The increasing adoption of cell-based assays in drug discovery and development, cancer research, and other biomedical studies is expected to drive the growth of the market in this region. Additionally, the increasing prevalence of chronic diseases, such as cancer and autoimmune disorders, is also expected to drive the growth of the market in this region. Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2023 to 2031. The increasing focus on biomedical research and development, growing investments in healthcare infrastructure, and the rising prevalence of chronic diseases in the region are expected to drive the growth of the market in this region. The increasing adoption of personalized medicine and the growing demand for cell-based assays for drug discovery and development is also expected to drive the growth of the market in this region.

Competition to Intensify During the Forecast Period

The global gentle cell dissociation reagent market is highly competitive and is characterized by the presence of several major players. Some of the key players operating in the market include Thermo Fisher Scientific, Inc., Merck KGaA, STEMCELL Technologies, ATCC, MiltenyiBiotec GmbH, Biological Industries, PromoCell GmbH, Corning Incorporated, Lonza, HiMedia Laboratories and Other Notable Players. These companies are actively involved in strategic initiatives, such as mergers and acquisitions, collaborations, partnerships, and product launches, to strengthen their market position. For instance, in May 2021, Thermo Fisher Scientific, Inc. announced the launch of its new Gibco CTS Rotea Counterflow Centrifugation System, a next-generation cell therapy manufacturing platform. The platform includes gentle cell dissociation reagents that are optimized for the production of cell and gene therapies. The increasing focus on personalized medicine, the growing demand for cell-based assays in drug discovery and development, and the rising prevalence of chronic diseases are expected to drive the growth of the market during the forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Gentle Cell Dissociation Reagent market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Gentle Cell Dissociation Reagent market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Connective Tissue
  • Epithelial Tissue
  • Other

Application

  • Laboratory
  • Hospital
  • Other

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Gentle Cell Dissociation Reagent market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Gentle Cell Dissociation Reagent market?
  • Which is the largest regional market for Gentle Cell Dissociation Reagent market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Gentle Cell Dissociation Reagent market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Gentle Cell Dissociation Reagent market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Gentle Cell Dissociation Reagent Market
  • 2.2. Global Gentle Cell Dissociation Reagent Market, By Type, 2022 (US$ Million)
  • 2.3. Global Gentle Cell Dissociation Reagent Market, By Application, 2022 (US$ Million)
  • 2.4. Global Gentle Cell Dissociation Reagent Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Gentle Cell Dissociation Reagent Market: Competitive Analysis

  • 3.1. Market Positioning of Key Gentle Cell Dissociation Reagent Market Vendors
  • 3.2. Strategies Adopted by Gentle Cell Dissociation Reagent Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Gentle Cell Dissociation Reagent Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Gentle Cell Dissociation Reagent Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Connective Tissue
    • 5.3.2. Epithelial Tissue
    • 5.3.3. Other

6. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Laboratory
    • 6.3.2. Hospital
    • 6.3.3. Other

7. North America Gentle Cell Dissociation Reagent Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
  • 7.3. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
  • 7.4.Gentle Cell Dissociation Reagent Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Gentle Cell Dissociation Reagent Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
  • 8.3. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
  • 8.4.Gentle Cell Dissociation Reagent Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.4.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.5.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.6.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Gentle Cell Dissociation Reagent Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
  • 9.3. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
  • 9.4.Gentle Cell Dissociation Reagent Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.4.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.5.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.6.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

10. Latin America Gentle Cell Dissociation Reagent Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
  • 10.3. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
  • 10.4.Gentle Cell Dissociation Reagent Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Gentle Cell Dissociation Reagent Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
  • 11.3. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
  • 11.4.Gentle Cell Dissociation Reagent Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.1.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.2.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.3.1. Gentle Cell Dissociation Reagent Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Thermo Fisher Scientific, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Merck KGaA
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. STEMCELL Technologies
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. ATCC
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. MiltenyiBiotec GmbH
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Biological Industries
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. PromoCell GmbH
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Corning Incorporated
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Lonza
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. HiMedia Laboratories
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Other Notable Players
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives